May 12, 2026 ProMIS Neurosciences Announces First Quarter 2026 Financial Results and Provides Corporate Highlights
Apr 27, 2026 Targeting underlying causes of neurodegenerative diseases | 2026 Bloom Burton & Co. Healthcare Investor Conference